GeoVax Labs Inc (GOVX): Dr. Thomas Monath, NLNK Chief Science Of...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	15
Posts	1647
Boards Moderated	0
Alias Born	05/15/2015

remind2

Re: None

Tuesday, 01/31/2017 11:20:59 PM

Tuesday, January 31, 2017 11:20:59 PM

Dr. Thomas Monath, NLNK Chief Science Officer & GOVX Science Advisory Board Chairman.

Dr. Thomas Monath: Developed the 100% effective Ebola vax for NLNK in partnership with Merck. NLNK is heating up nicely since that news hit a few weeks ago. Scroll down link for Dr. Monath bio.
http://www.newlinkgenetics.com/about-us/management/.

Dr. Thomas Monath recently became Chairman of the GeoVax Science Advisory Board. The Board is a whos who of vaccine science. Take a look at the names & resumes. Investors are slowly starting to take notice of tiny GeoVax.
https://www.geovax.com/news-events/entry/2017/01/03/geovax-announces-formation-of-scientific-advisory-board.html

NOTE: Bio/pharma investors that know the vaccine sector know these Science Advisory Board member names. One more brick in the wall for GeoVax in regard to industry and investor respect. GeoVax stakeholders are sitting in the catbird seat right now.